mja.com.au | The Medical Journal of Australia

Home | Issues | MJA shop | MJA Careers | Contact | Topics | Search | RSS  | Login | Buy full access

For Debate

The salt dilemma: some answers, many questions

M Gary Nicholls and A Mark Richards

MJA 1999; 170: 178-180
  

Back icon  The 100-year conflict: Introduction
Back icon  Universal recommendations for sodium intake should be avoided
Back icon  Restriction of salt intake is needed to ameliorate the cardiovascular disease epidemic
Introduction The many studies linking dietary sodium intake with blood pressure present conflicting views on the benefits and risks of salt restriction. Reviews, and more recently meta-analyses (which, as discussed by Swales,46 must be viewed with caution), have become commonplace in the struggle to reach firm conclusions about the importance of dietary sodium in contributing to raised blood pressure levels and the cardiovascular complications of hypertension. The continuing debate reflects inadequacies in the information.

We present a personal view of, firstly, whether moderate dietary sodium restriction in Western society reduces arterial pressure; secondly, whether such dietary sodium restriction reduces the complications of hypertension; thirdly, whether sodium restriction has adverse effects; and finally, whether a population approach to reducing dietary sodium is practical.

Does moderate restriction of dietary sodium reduce arterial pressure?
Most studies of dietary sodium restriction have been short term. Furthermore, vital methodological features (eg, using objective techniques for measuring blood pressure, and randomisation of dietary regimens) have often been ignored. Many of these trials would be considered unacceptable were antihypertensive drugs rather than dietary sodium being scrutinised.

From our overview of studies in Western countries, we conclude that restricting a population's dietary sodium intake to about 80-100 mmol/day has a minor and variable effect on arterial pressure. A majority of people show a small fall in arterial pressure, but a sizeable minority exhibit no change or even a slight rise. An antihypertensive effect is most readily seen in the elderly, in African Americans and in people with moderate to severe hypertension.37,47-49 Younger subjects and those who are normotensive or have mild hypertension generally exhibit little or no fall in arterial pressures.49,50 Individual blood pressure responses relate in part to activation of the renin-angiotensin and sympathetic systems as dietary sodium intake is reduced.41,51-53

Effects of dietary sodium restriction on complications of hypertension
We are not aware of interventional data demonstrating that moderate dietary sodium restriction either reduces or increases the complications of hypertension, namely stroke, myocardial infarction, cardiac failure or renal failure.

Does dietary sodium restriction have adverse effects?
Dietary sodium restriction stimulates the renin-angiotensin system, plasma aldosterone and circulating catecholamines,12 most obviously in young subjects. Whether long term activation of these neurohormonal systems is hazardous is a vexed question. Some researchers (with Laragh and colleagues usually leading) consider that heightened activity of the renin-angiotensin system constitutes a risk factor for coronary heart disease, stroke, retinopathy and left ventricular hypertrophy, especially in hypertensive patients.14,21,44,54-57 Others have found no evidence to support the view that the renin-angiotensin system constitutes a cardiovascular risk factor in hypertensive or normotensive subjects.58-60 Recently, the report from the first National Health and Nutrition Examination Survey (NHANES I) added fuel to the controversy by documenting an inverse association between all-cause mortality and sodium intake in a representative sample of 11 346 adults in the United States.6 Vigorous debate followed in the letters columns of journals, much of it focused on the adequacy (or otherwise) of using a single assessment of sodium intake based on diet recall.

There is no lack of animal and experimental information demonstrating the vascular and cardiac toxicity of angiotensin II,61 which, when added to the accumulated data from New York in particular,14,21,44 raises questions about the advisability of restricting dietary sodium intake over years and decades. These data, however, are difficult to reconcile with evidence that a high dietary sodium intake (which should suppress renin secretion) is claimed to have adverse effects on blood vessels and the heart beyond, and perhaps independent of, any action via an increase in arterial pressure.62-64 Information from a small number of laboratories suggests that raised levels of aldosterone, like angiotensin II, may have adverse effects, particularly on the heart.65,66 Whether a chronic threefold elevation in aldosterone levels with restriction of dietary sodium12 could offset to a greater or lesser extent any benefits from a concomitant fall in arterial pressure is unknown.

It can be argued that diuretic-based antihypertensive treatment, the effects of which are in many ways similar to those of dietary sodium restriction, has been shown to reduce the cardiovascular complications of hypertension notwithstanding stimulation of angiotensin II, aldosterone and catecholamine levels.67-69 However, these were intervention trials of about three to five years' duration and often in elderly people with hypertension. Extrapolation from short term, diuretic-based trials in elderly patients to longer term dietary sodium restriction in young and middle-aged subjects could be hazardous.

Dietary sodium restriction has been claimed to increase plasma levels of total and low density lipoprotein cholesterol, to reduce insulin sensitivity, to impair sleep and worsen fatigue, and to be undesirable in pregnancy.12,70-73 Whether such changes are significant or important in the long term is unknown. Some bravely dismiss such possibilities outright.74

The practicality of reducing dietary sodium in whole populations
Although there are exceptions,75 most researchers have found it difficult to achieve a substantial reduction in dietary sodium consumption in a majority of subjects in Western populations.76,77

Many foods, particularly processed foods, have a high sodium content, and presumably this is preferred by many. If food companies reduced the sodium content of foods considerably, a daily intake in the range of 80-100 mmol/day would be more readily attained. But should industry be encouraged, even forced, to reduce the sodium content of foods when evidence of benefit over risk remains so tenuous?

Conclusions
  • Dietary sodium restriction is advisable in all patients with hypertension who are receiving antihypertensive drugs, with the possible exception of monotherapy with a calcium channel antagonist, as the antihypertensive action of this drug is arguably little altered by the level of dietary sodium intake.

  • Dietary sodium restriction is advisable as a trial over a period of months in all patients with mild to moderate hypertension, especially the elderly,49,78 as part of a "hygienic" approach to reduce blood pressure, which should include weight loss in the obese, restriction of alcohol intake in heavy drinkers, and regular exercise in the sedentary.

  • The realities of life dictate that few patients can alter more than one or two lifestyle habits in the long term, and, given a choice of which to pursue based on evidence of benefit versus risk, we recommend weight loss, restriction of alcohol and regular moderate exercise ahead of dietary sodium restriction. Other lifestyle changes might repay further investigation.79

As noted already, the medical literature relating to dietary sodium, blood pressure and its complications is vast and conflicting. The controversy is well reflected in a recent overview in Science, in which the real difficulties attending interpretation of the Intersalt study,80 and especially reanalysis of the original data,81 are discussed.3 More information of an objective nature is required before we admonish whole populations to restrict dietary sodium intake, as, in our view (which has not changed in 14 years82), the balance between benefit and risk is unknown. Regarding lifestyle matters and general health (not just in relation to hypertension), energy is better directed to areas where the evidence is more secure, such as smoking cessation, prevention of obesity and regular moderate exercise.

Conflict of interest
None. We do not have any connection with or receive funds from the food and salt industries or any related commercial interests.

References
  1. Chapman CB, Gibbons TB. The diet and hypertension. A review. Medicine 1950; 29: 29-69.
  2. National Health and Medical Research Council. Implementing the dietary guidelines for Australians. Canberra: NHMRC/AGPS, 1989: 21.
  3. Taubes G. The (political) science of salt. Science 1998; 281: 898-907.
  4. Beard TC, Woodward DR, Ball PJ, et al. The Hobart Salt Study 1995: few meet national sodium intake target. Med J Aust 1997; 166: 404-407.
  5. Kincaid-Smith PS. Salt intake, cardiovascular disease and public health [letter]. Med J Aust 1997; 167: 283-284.
  6. Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet 1998; 351: 781-785.
  7. de Wardener H, MacGregor GA. Sodium intake and mortality [letter]. Lancet 1998; 351: 1508.
  8. Engelman K. Sodium intake and mortality [letter]. Lancet 1998; 351: 1508-1509.
  9. Karppanen H, Mervaala E. Sodium intake and mortality [letter]. Lancet 1998; 351: 1509.
  10. Alderman MH, Cohen H, Madhavan S. Sodium intake and mortality [letter]. Lancet 1998; 351: 1509-1510.
  11. Denton D, Weisinger R, Mundy NI, et al. The effect of increased salt intake on blood pressure of chimpanzees. Nature Med 1995; 1: 1009-1016.
  12. Graudal NA, Galloe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. JAMA 1998; 279: 1383-1391.
  13. Laragh JH, Baer HR, Buhler FR, et al. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med 1972; 52: 633-652.
  14. Alderman MH, Madhavan S, Ooi WL, et al. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324: 1098-1104.
  15. Kincaid-Smith P, McMichael J, Murphy EA. The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Q J Med 1958; 217: 117-153.
  16. Griffin SA, Brown WCB, MacPherson F, et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991; 17: 626-635.
  17. Johnston Cl, Jandeleit K, Mooser V, et al. Angiotensin-converting enzyme and its inhibition in the heart and blood vessels. J Cardiovasc Pharmacol 1992; 20(Suppl B): S6-S11.
  18. Thybo NK, Stephens N, Cooper A. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25: 474-481.
  19. Mancini GB, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 94: 258-264.
  20. Mohring J, Petri M, Szokol M, et al. Effects of saline drinking on malignant course of renal hypertension in rats. Am J Physiol 1976; 230: 849-857.
  21. Alderman MH, Ooi WL, Cohen H, et al. Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. Am J Hypertens 1997; 10: 1-8.
  22. Alderman MH, Madhavan S, Cohen H, et al. Low urinary sodium associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension 1995; 25: 1144-1152.
  23. Tunstall-Pedoe H, Woodward M, Tavendale R, et al. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ 1997; 315: 722-729.
  24. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham Study. Am J Cardiol 1971; 27: 335-346.
  25. Lowenstein FW. Blood pressure in relation to age and sex in the tropics and sub-tropics. A review of the literature and an investigation of two tribes of Brazil Indians. Lancet 1961; 1: 389-392.
  26. Sasaki N. High blood pressure and the salt intake of the Japanese. Jpn Heart J 1962; 3: 313-324.
  27. Page LB, Vandervert D, Nader K, et al. Blood pressure, diet and body form in traditional nomads of the Qash'qui tribe, Southern Iran. Acta Cardiologica J 1978; 33: 102.
  28. Page LB, Danon A, Moellering RC Jr. Antecedents of cardiovascular disease in six Solomon Island societies. Circulation 1974; 49: 1132.
  29. Prior IA, Evans JG, Harvey HP, et al. Sodium intake and blood pressure in two Polynesian populations. N Engl J Med 1968; 279: 515-520.
  30. Harmsen E, Leenen FH. Dietary sodium induced cardiac hypertrophy. Can J Physiol Pharmacol 1992; 70: 580-586.
  31. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation 1988; 78: 951-956.
  32. Gill JR, Gullner HG, Lake R, et al. Plasma and urinary catecholamines in salt- sensitive idiopathic hypertension. Hypertension 1988; 11: 312-319.
  33. Morgan T, Gillies A, Morgan G, et al. Hypertension treated by salt restriction. Lancet 1978; 1: 227-230.
  34. Morgan T, Nowson C. The role of sodium restriction in the management of hypertension. Can J Physiol Pharmacol 1986; 64: 786-792.
  35. MacGregor GA, Markandu ND, Best FE, et al. Double-blind randomised cross-over trial of moderate sodium restriction in essential hypertension. Lancet 1982; 1: 351-355.
  36. Chalmers J, Morgan TO, Doyle AE, et al. Australian National Health and Medical Research Council dietary salt study in mild hypertension. J Hypertens 1986; 4(Suppl 6): S629-S637.
  37. Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Modest reduction in dietary salt intake reduces blood pressure. Lancet 1989; 1: 399-402.
  38. Nowson CA, Morgan TO. Change in blood pressure in relation to change in nutrients effected by manipulation of dietary sodium and potassium. Clin Exp Pharmacol Physiol 1988; 15: 225-242.
  39. Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980; 1: 1261-1267.
  40. Watts GC, Edwards C, Hart JT, et al. Dietary sodium restriction in mild hypertension in general practice. BMJ 1983; 286: 432-436.
  41. Richards AM, Nicholls MG, Espiner A, et al. Blood pressure response to moderate sodium restriction and to potassium supplementation in mild hypertension. Lancet 1984; 1: 757-761.
  42. Luft FC, Weinberger MH, Grim CF. Sodium sensitivity and resistance in normotensive humans. Am J Med 1982; 72: 726-736.
  43. Myers J, Morgan T. The effect of sodium intake on the blood pressure related to age and sex. Clin Exp Hypertens 1983; A5: 99-118.
  44. Brunner HR, Laragh JH, Baer L, et al. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972; 286: 441-449.
  45. Alderman MH, Laragh JH. Low urinary sodium and myocardial infarction. Hypertension 1996; 27: 156-157.
  46. Swales JD. Dietary salt and blood pressure: the role of meta-analyses. J Hypertens 1991; 9(Suppl 6): S42-S46.
  47. Weinberger MH, Miller JZ, Luft FC, et al. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986; 8(Suppl 11): II-127-II-134.
  48. Grobbee DE, Hofman A. Does sodium restriction lower blood pressure? BMJ 1986; 293: 27-29.
  49. Midgley JP, Matthew AG, Greenwood CMT, Logan AG. Effect of reduced dietary sodium on blood pressure. JAMA 1996; 275: 1590-1597.
  50. Cooper R, Van Horn L, Liu K, et al. A randomized trial on the effect of decreased dietary sodium intake on blood pressure in adolescents. J Hypertens 1984; 2: 361-366.
  51. Parfrey PS, Markandu ND, Roulston JE, et al. Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension. BMJ 1981; 283: 94-97.
  52. Koolen MI, van Brummelen P. Sodium sensitivity in essential hypertension: Role of the renin-angiotensin-aldosterone system and predictive value of an intravenous frusemide test. J Hypertens 1984; 2: 55-59.
  53. Krekels MME, Schaper NC, de Leeuw PW. Sensitivity of blood pressure and renin activation during sodium restriction. Hypertension 1997; 30: 1216-1222.
  54. Jorgensen H, Sundsfjord JA. The relation of plasma renin activity to left ventricular hypertrophy and retinopathy in patients with arterial hypertension. Acta Med Scand 1974; 196: 307-313.
  55. Schmieder RE, Messerli FH, Garavaglia GE, et al. Does the renin-angiotensin- aldosterone system modify cardiac structure and function in essential hypertension? Am J Med 1988; 84(Suppl 3A): 136-141.
  56. Harrap SB, Dominiczak AF, Fraser R, et al. Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation 1996; 93: 1148-1154.
  57. Aronow WS, Ahn C, Kronzon I, Gutstein H. Association of plasma renin activity and echocardiographic left ventricular hypertrophy with frequency of new coronary events and new atherothrombotic brain infarction in older persons with systemic hypertension. Am J Cardiol 1997; 79: 1543-1545.
  58. Russell GI, Bing RF, Thurston H, Swales JD. Plasma renin in hypertensive patients: significance in relation to clinical and other biochemical features. Q J Med 1980; 49: 385-394.
  59. Meade TW, Imeson JD, Gordon D, Peart WS. The epidemiology of plasma renin. Clin Sci 1983; 64: 273-280.
  60. Meade TW, Cooper JA, Peart WS. Plasma renin activity and ischemic heart disease. N Engl J Med 1993; 329: 616-619.
  61. Gavras I, Gavras H. Angiotensin II -- possible adverse effects on arteries, heart, brain and kidney: experimental, clinical and epidemiological evidence. In: Robertson JIS, Nicholls MG, editors. The renin-angiotensin system. London: Gower Medical Publishing, 1993: 40.1-40.11.
  62. Tobian L, Hanlon S. High sodium chloride diets injure arteries and raise mortality without changing blood pressure. Hypertension 1990; 15: 900-903.
  63. Perry U, Beevers DG. Salt intake and stroke: a possible direct effect. J Human Hypertens 1992; 6: 23-25.
  64. Messerli FH, Schmieder RE, Weir MR. Salt. A perpetrator of hypertensive target organ disease? Arch Intern Med 1997; 157: 2449-2452.
  65. Campbell SE, Diaz-Arias AA, Weber KT. Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Pressure 1992; 1: 149-156.
  66. Young M, Fullerton M, Dilley R, Funder J. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 1994; 93: 2578-2583.
  67. Amery A, BirkenhŠger, Brixko P, et al. Mortality and morbidity results from the European Working Party on high blood pressure in the elderly trial. Lancet 1985; 1: 1349-1354.
  68. SHEP Cooperative Research Group: prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255-3264.
  69. Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997; 278: 212-216.
  70. Alderman MH, Lamport B. Moderate sodium restriction. Do the benefits justify the hazards? Am J Hypertens 1990; 3: 499-504.
  71. Wassertheil-Smoller S, Blaufox D, Oberman A, et al. Effect of antihypertensives on sexual function and quality of life: The TAIM Study. Ann Intern Med 1991; 114: 613-620.
  72. Petrie JR, Morris AD, Minamisawa K, et al. Dietary sodium restriction impairs insulin sensitivity in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 1552-1557.
  73. Iwaoka T, Umeda T, Inoue J, et al. Dietary NaCI restriction deteriorates oral glucose tolerance in hypertensive patients with impairment of glucose tolerance. Am J Hypertens 1994; 7: 460-463.
  74. de Wardener HE, Kaplan NM. On the assertion that a moderate restriction of sodium intake may have adverse health effects. Am J Hypertens 1993; 6: 810-814.
  75. Thaler BI, Paulin JM, Phelan EL, Simpson FO. A pilot study to test the feasibility of salt restriction in a community. N Z Med J 1982; 95: 839-842.
  76. Staessen J, Bulpitt CJ, Fagard R, et al. Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. J Hypertens 1988; 6: 965-973.
  77. Hashimoto J, Imai Y, Minami N, et al. Compliance with long-term dietary salt restriction in hypertensive outpatients. Clin Exp Hypertens 1994; 16: 729-739.
  78. Cappuccio FP, Markandu ND, Carney C, et al. Double-blind randomised trial of modest salt restriction in older people. Lancet 1997; 350: 850-854.
  79. Timio M, Verdecchia P, Venanzi S, et al. Age and blood pressure changes. A 20-year follow-up study in nuns in a secluded order. Hypertension 1988; 12: 457-461.
  80. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297: 319-328.
  81. Elliott P, Stamler J, Nichols R, et al. Intersalt revisited: further analysis of 24 hour sodium excretion and blood pressure within and across populations. BMJ 1996; 312: 1249-1253.
  82. Nicholls MG. Reduction of dietary sodium in Western society. Benefit or risk? Hypertension 1984; 6: 795-801.

Authors' details
Department of Medicine, Christchurch Hospital, Christchurch, New Zealand.
M Gary Nicholls, FRACP, Professor of Medicine.
A Mark Richards, FRACP, Professor of Medicine.

Reprints will not be available from the authors.
Correspondence: Professor M G Nicholls, Department of Medicine, Christchurch Hospital, PO Box 4345, Christchurch, New Zealand.
Email: bgriffinATchmeds.ac.nz

©MJA 1998
Make a comment


Home | Issues | MJA shop | Terms of use | MJA Careers | More... | Contact | Topics | Search | RSS 

mja.com.au | The Medical Journal of Australia  


Readers may print a single copy for personal use. No further reproduction or distribution of the articles should proceed without the permission of the publisher. For permission, contact the Australasian Medical Publishing Company.
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au>".
<URL: http://www.mja.com.au/> © 1998 Medical Journal of Australia.
We appreciate your comments.